← Leaderboards
Thomas Hope
University Of California, San Francisco
$3,566,163
Attributed
$6,676,515
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,676,515 · 3
By mechanism
R01$6,676,515 · 3
Top collaborators
- Richard Andre Laforest6 shared
- Felix Yi-Chung Feng5 shared
- Rahul Aggarwal2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Daniel B Vigneron$43,424,992
- Robert A Bok$3,250,145
- Rahul Aggarwal$5,953,056
- Susan Halabi$7,630,539
- Felix Yi-Chung Feng$6,764,664
Others in their field
Other Emerging Leaders on “Uptake”
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Paula Gonzalez-Maya · Fundacion Inciensa$17,061,460
- Emmanuel Aja Oga · Research Triangle Institute$16,442,002
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Rainer Lohmann · University Of Rhode Island$14,400,221
Research focus
UptakePositron-Emission TomographyImageBaseData SetClinical TrialsTissuesBiopsyTumorRadioligandResponseToxic EffectTargeted TreatmentRadiationNovel TherapeuticsFolh1 GeneLesionDoseCollaborationsEvaluationPropertyBloodAnimal ModelBiological Markers
Grant awards (14)
MELT: Modulation of PSMA Expression for Lutetium Therapy$455,810
R01 · FY2025 · CA · contact PI
MELT: Modulation of PSMA Expression for Lutetium Therapy$618,546
R01 · FY2024 · CA · contact PI
MELT: Modulation of PSMA Expression for Lutetium Therapy$638,248
R01 · FY2022 · CA · contact PI
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials$200,396
R01 · FY2022 · CA · contact PI
MELT: Modulation of PSMA Expression for Lutetium Therapy$651,214
R01 · FY2021 · CA · contact PI
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials$305,100
R01 · FY2021 · CA · contact PI
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials$545,338
R01 · FY2020 · CA · contact PI
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer$368,455
R01 · FY2020 · CA
MELT: Modulation of PSMA Expression for Lutetium Therapy$195,347
R01 · FY2020 · CA · contact PI
MELT: Modulation of PSMA Expression for Lutetium Therapy$647,080
R01 · FY2019 · CA · contact PI
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials$533,139
R01 · FY2019 · CA · contact PI
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer$366,367
R01 · FY2019 · CA
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials$553,835
R01 · FY2018 · CA · contact PI
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials$597,640
R01 · FY2017 · CA · contact PI